Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,730 across all filing types
Latest filing 2025-11-05 Investor Presentation
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
114年11月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a schedule and summary of upcoming and past investor presentations (法人說明會) by a company, including dates, times, locations, and links to presentation materials. It specifically mentions presentations to investors about financial and operational status for certain periods (e.g., third quarter). The document does not contain actual financial statements or detailed financial analysis but rather information about investor meetings and presentation materials. This matches the definition of an Investor Presentation (IP). The document length is short (1248 characters), but it contains direct links to presentation PDFs and details about the events, indicating it is the presentation information itself, not just an announcement of a report. Therefore, the correct classification is Investor Presentation (IP).
2025-11-05 Chinese
公告本公司114年第三季合併財務報告董事會召開日期為 114年11月12日
Regulatory Filings Classification · 95% confidence The document is a short announcement (543 characters) from a company (1795 美時) stating the date of the board meeting to be held on 114/11/12 to discuss the third quarter consolidated financial report. It does not contain the financial report itself but announces the upcoming board meeting and the expected report presentation. The document is an announcement about the timing of a financial report discussion, not the report itself. According to the MENU VS MEAL RULE, such short notices about report meetings are classified as Regulatory Filings (RNS).
2025-11-04 Chinese
114年10月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, general managers, and other executives, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on personal share transactions and holdings by company directors and executives. There is no indication of financial results, audit opinions, meeting materials, or other report types. The document is not a report publication announcement or a certification letter but a direct disclosure of insider share transactions and holdings. Therefore, it fits the category of Director's Dealing (DIRS).
2025-11-04 Chinese
114年10月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, independent directors, general managers, and other executives. It lists the number of shares held, pledged shares, and related percentages. The content focuses on insider shareholdings and their changes, which aligns with reporting personal share transactions or holdings by company directors and executives. There is no indication of financial results, meeting materials, voting results, or other report types. The document is not a report publication announcement or a certification but a direct disclosure of insider shareholdings. Therefore, the document fits the category of Director's Dealing (DIRS). The document length is 3780 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report.
2025-11-04 Chinese
本公司受邀參加高盛證券舉辦之APAC Healthcare Corporate Day 2025
Investor Presentation Classification · 85% confidence The document is a short announcement (717 characters) about the company 1795 美時 being invited to participate in the APAC Healthcare Corporate Day 2025 organized by Goldman Sachs. It specifies the date, time, and location of the investor presentation and mentions that the company will explain its half-year operational progress and industry development to institutional investors. There is no detailed financial data or full transcript, only an announcement of an upcoming investor presentation event. According to the 'MENU VS MEAL' rule, this is an announcement of a presentation, not the presentation itself. Therefore, the document fits best under 'Investor Presentation' (IP) category as it relates to a detailed presentation for investors focusing on financials and strategy, even though the full presentation is not included here, the announcement is about such a presentation event.
2025-11-03 Chinese
114年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (美時) providing details about fund lending balances and endorsement guarantees for the current and previous months, including limits and cumulative amounts. The content is concise (619 characters) and focuses on specific financial data related to fund lending and guarantees, without broader financial statements or management discussion. It does not present a full financial report but rather a regulatory disclosure of specific financial information. Given the nature and length, it fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2025-10-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.